# Core Task
Analyze the literature to classify the primary therapeutic effect of the natural product-based drug combination into one of three categories: (1) enhancing drug efficacy by augmenting sensitivity and achieving synergy, (2) decreasing adverse drug reactions, or (3) reversing drug resistance.
Literature to analyze: `dataset\NPCDR\27980427.pdf`, `dataset\NPCDR\25653233.pdf`, `dataset\NPCDR\23429291.pdf`, `dataset\NPCDR\21088503.pdf`, `dataset\NPCDR\32872376.pdf`, `dataset\NPCDR\29626307.pdf`

# Output Requirements & File Path
- Output format: A JSON list of dictionaries with "PMID" and "TypeID". 
- "PMID" is the filename, and "TypeID" is the classification category mentioned above (int).
- Save Path: Save the complete list to: `/root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json`
- Intermediate Storage Path: All intermediate code generated during execution, downloaded files, and temporary results must be stored in `/root/autodl-tmp/biomni_v20260208_tmp/kimi-k2.5/npcdr_extract_1/`

# Example Output (For Reference Only)
[
  {
      "PMID": "15380427",
      "TypeID": 2
  },
  {
      "PMID": "25653532",
      "TypeID": 1
  }
]

I'll analyze the literature from the 6 PDF files to classify the primary therapeutic effect of natural product-based drug combinations. Let me start by creating a plan and executing it step by step.

## Plan:

1. [ ] Set up the working directory and check the PDF files
2. [ ] Extract text from all 6 PDF files using pdfplumber
3. [ ] Analyze each paper's content to identify the therapeutic effect category
4. [ ] Create the output JSON with PMID and TypeID
5. [ ] Save the results to the specified path

<execute>
import os
import json
import pdfplumber
import re

# Set up paths
pdf_dir = "dataset/NPCDR"
tmp_dir = "/root/autodl-tmp/biomni_v20260208_tmp/kimi-k2.5/npcdr_extract_1/"
output_path = "/root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json"

# Create directories if they don't exist
os.makedirs(tmp_dir, exist_ok=True)
os.makedirs(os.path.dirname(output_path), exist_ok=True)

# List of PDF files to analyze
pdf_files = [
    "27980427.pdf",
    "25653233.pdf",
    "23429291.pdf",
    "21088503.pdf",
    "32872376.pdf",
    "29626307.pdf"
]

print("Step 1: Checking PDF files...")
for pdf_file in pdf_files:
    full_path = os.path.join(pdf_dir, pdf_file)
    if os.path.exists(full_path):
        print(f"  [✓] {pdf_file} exists")
    else:
        print(f"  [✗] {pdf_file} NOT FOUND")
</execute>
<observation>Step 1: Checking PDF files...
  [✗] 27980427.pdf NOT FOUND
  [✗] 25653233.pdf NOT FOUND
  [✗] 23429291.pdf NOT FOUND
  [✗] 21088503.pdf NOT FOUND
  [✗] 32872376.pdf NOT FOUND
  [✗] 29626307.pdf NOT FOUND
</observation>
<execute>
# Let's explore the directory structure to find the PDFs
import os

print("Exploring directory structure...")
for root, dirs, files in os.walk("dataset"):
    level = root.replace("dataset", "").count(os.sep)
    indent = " " * 2 * level
    print(f"{indent}{os.path.basename(root)}/")
    subindent = " " * 2 * (level + 1)
    for file in files:
        if file.endswith(".pdf"):
            print(f"{subindent}{file}")
            print(f"  Full path: {os.path.join(root, file)}")
</execute>
<observation>Exploring directory structure...
</observation>
<execute>
# Let's check the current working directory and look for files
import os
print("Current working directory:", os.getcwd())
print("\nListing files in current directory:")
print(os.listdir("."))

# Check if there's a dataset directory
if os.path.exists("dataset"):
    print("\nListing files in dataset directory:")
    print(os.listdir("dataset"))
</execute>
<observation>Current working directory: /root/biodatalab

Listing files in current directory:
['assistant', 'benchmark', 'data', 'evaluate_bash_scripts', 'evaluate_results', 'log', 'mapper_logs', 'operation_env', 'paper_analysis', 'pred_results', 'pred_results_new', 'tmp', 'tmp_new', 'traitdata', '.env.template', 'README.md', 'elton_birds_species_list.csv', 'env_install.sh', 'environment.yaml', 'environment.yml', 'example_log_trajectory.json', 'example_log_trajectory_zjt.json', 'output.pdbqt', 'process_pdbs.py', 'retrieve_cyano.py', 'run_evaluate_batch_biomni.py', 'run_evaluate_batch_biomni.sh', 'get_gwas.py', 'run_evaluate_batch_biomni_for_bash.py', 'run_evaluate_case_biomni.py', 'run_evaluate_case_stella.py', 'run_evaluate_case_tooluniverse.py', 'run_only_evaluate.py', 'run_qc_filtering.py', '1crn.pdb.gz', 'run_qc_filtering_corrected.py', 'count_genes.py', '5yuv.pdb.gz', 'run_qc_filtering_corrected_v2.py', '6a1f.pdb.gz', '6a1g.pdb.gz', 'run_qc_filtering_corrected_v3.py', 'run_qc_filtering_final.py', 'script.py', 'metadata_script.py', 'sasa_script.py', 'sasa_script_v2.py', 'process_drugs.py', 'search_geo.py', 'search_sra.py', 'search_geo_v2.py', 'final_extraction.py', 'SRR31029759.sorted.bam', 'fix_sra_extraction.py', 'raw_counts_htseq.txt', 'debug_extraction.py', 'robust_search.py', 'simple_search.py', 'exhaustive_search.py', 'fix_sra_linking.py', 'GSE210066_metadata.csv', 'manual_check_gse.py', 'GSE210066_metadata_fixed.csv', 'fix_sra_search.py', 'final_sra_search.py', 'tmp.json', 'temp.json', 'fix_final_v2.py', 'retrieve_srrs.py', 'GSE210066_cell_stats.csv', 'ultimate_search.py', 'search_af_2025.py']
</observation>
<execute>
# Search for NPCDR directory and PDF files
import os

# Look for NPCDR directory anywhere
for root, dirs, files in os.walk("/root"):
    if "NPCDR" in dirs:
        npc_dir = os.path.join(root, "NPCDR")
        print(f"Found NPCDR at: {npc_dir}")
        print("Contents:")
        for item in os.listdir(npc_dir):
            print(f"  {item}")
        break

# Also search for the specific PDF files
print("\nSearching for specific PDF files...")
for root, dirs, files in os.walk("/root"):
    for file in files:
        if file in ["27980427.pdf", "25653233.pdf", "23429291.pdf", "21088503.pdf", "32872376.pdf", "29626307.pdf"]:
            print(f"Found {file} at: {os.path.join(root, file)}")
</execute>
<observation>Found NPCDR at: /root/biodatalab/benchmark/dataset/NPCDR
Contents:
  21088503.pdf
  23429291.pdf
  25653233.pdf
  27980427.pdf
  29626307.pdf
  32872376.pdf
  paper.pdf

Searching for specific PDF files...
Found 21088503.pdf at: /root/biodatalab/benchmark/dataset/NPCDR/21088503.pdf
Found 23429291.pdf at: /root/biodatalab/benchmark/dataset/NPCDR/23429291.pdf
Found 25653233.pdf at: /root/biodatalab/benchmark/dataset/NPCDR/25653233.pdf
Found 27980427.pdf at: /root/biodatalab/benchmark/dataset/NPCDR/27980427.pdf
Found 29626307.pdf at: /root/biodatalab/benchmark/dataset/NPCDR/29626307.pdf
Found 32872376.pdf at: /root/biodatalab/benchmark/dataset/NPCDR/32872376.pdf
</observation>
<execute>
import os
import json
import pdfplumber
import re

# Correct paths
pdf_dir = "/root/biodatalab/benchmark/dataset/NPCDR"
tmp_dir = "/root/autodl-tmp/biomni_v20260208_tmp/kimi-k2.5/npcdr_extract_1/"
output_path = "/root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json"

# Create directories if they don't exist
os.makedirs(tmp_dir, exist_ok=True)
os.makedirs(os.path.dirname(output_path), exist_ok=True)

# List of PDF files to analyze
pdf_files = [
    "27980427.pdf",
    "25653233.pdf",
    "23429291.pdf",
    "21088503.pdf",
    "32872376.pdf",
    "29626307.pdf"
]

print("Step 2: Extracting text from PDF files...")

def extract_text_from_pdf(pdf_path, max_pages=5):
    """Extract text from first few pages of PDF"""
    text = ""
    try:
        with pdfplumber.open(pdf_path) as pdf:
            for i, page in enumerate(pdf.pages[:max_pages]):
                try:
                    page_text = page.extract_text()
                    if page_text:
                        text += f"\n--- Page {i+1} ---\n{page_text}"
                except:
                    continue
    except Exception as e:
        print(f"Error extracting from {pdf_path}: {e}")
    return text

# Extract and save text from each PDF
pdf_texts = {}
for pdf_file in pdf_files:
    pdf_path = os.path.join(pdf_dir, pdf_file)
    pmid = pdf_file.replace(".pdf", "")
    print(f"\nExtracting: {pdf_file}")
    
    text = extract_text_from_pdf(pdf_path)
    pdf_texts[pmid] = text
    
    # Save extracted text to temp file
    temp_file = os.path.join(tmp_dir, f"{pmid}.txt")
    with open(temp_file, 'w', encoding='utf-8') as f:
        f.write(text)
    
    # Print first 1000 characters for preview
    print(f"  Extracted {len(text)} characters")
    print(f"  Preview (first 1000 chars):")
    print(text[:1000])
    print("-" * 50)
</execute>
<observation>Step 2: Extracting text from PDF files...

Extracting: 27980427.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/27980427.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------

Extracting: 25653233.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/25653233.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------

Extracting: 23429291.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/23429291.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------

Extracting: 21088503.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/21088503.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------

Extracting: 32872376.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/32872376.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------

Extracting: 29626307.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/29626307.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------
</observation>
<execute>
import os
import json
import pdfplumber
import re

# Correct paths
pdf_dir = "/root/biodatalab/benchmark/dataset/NPCDR"
tmp_dir = "/root/autodl-tmp/biomni_v20260208_tmp/kimi-k2.5/npcdr_extract_1/"
output_path = "/root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json"

# Create directories if they don't exist
os.makedirs(tmp_dir, exist_ok=True)
os.makedirs(os.path.dirname(output_path), exist_ok=True)

# List of PDF files to analyze
pdf_files = [
    "27980427.pdf",
    "25653233.pdf",
    "23429291.pdf",
    "21088503.pdf",
    "32872376.pdf",
    "29626307.pdf"
]

print("Step 2: Extracting text from PDF files...")

def extract_text_from_pdf(pdf_path, max_pages=5):
    """Extract text from first few pages of PDF"""
    text = ""
    try:
        with pdfplumber.open(pdf_path) as pdf:
            for i, page in enumerate(pdf.pages[:max_pages]):
                try:
                    page_text = page.extract_text()
                    if page_text:
                        text += f"\n--- Page {i+1} ---\n{page_text}"
                except:
                    continue
    except Exception as e:
        print(f"Error extracting from {pdf_path}: {e}")
    return text

# Extract and save text from each PDF
pdf_texts = {}
for pdf_file in pdf_files:
    pdf_path = os.path.join(pdf_dir, pdf_file)
    pmid = pdf_file.replace(".pdf", "")
    print(f"\nExtracting: {pdf_file}")
    
    text = extract_text_from_pdf(pdf_path)
    pdf_texts[pmid] = text
    
    # Save extracted text to temp file
    temp_file = os.path.join(tmp_dir, f"{pmid}.txt")
    with open(temp_file, 'w', encoding='utf-8') as f:
        f.write(text)
    
    # Print first 1000 characters for preview
    print(f"  Extracted {len(text)} characters")
    print(f"  Preview (first 1000 chars):")
    print(text[:1000])
    print("-" * 50)
</execute>
<observation>Step 2: Extracting text from PDF files...

Extracting: 27980427.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/27980427.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------

Extracting: 25653233.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/25653233.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------

Extracting: 23429291.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/23429291.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------

Extracting: 21088503.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/21088503.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------

Extracting: 32872376.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/32872376.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------

Extracting: 29626307.pdf
Error extracting from /root/biodatalab/benchmark/dataset/NPCDR/29626307.pdf: name 'pdfplumber' is not defined
  Extracted 0 characters
  Preview (first 1000 chars):

--------------------------------------------------
</observation>
<execute>
# Check if pdfplumber is installed
import subprocess
subprocess.run(["pip", "list", "|", "grep", "pdfplumber"], shell=True)

# Install pdfplumber if not available
subprocess.run(["pip", "install", "pdfplumber"], check=True)
</execute>
<observation></observation>
<execute>
import os
import json
import re

# Correct paths
pdf_dir = "/root/biodatalab/benchmark/dataset/NPCDR"
tmp_dir = "/root/autodl-tmp/biomni_v20260208_tmp/kimi-k2.5/npcdr_extract_1/"
output_path = "/root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json"

# Create directories if they don't exist
os.makedirs(tmp_dir, exist_ok=True)
os.makedirs(os.path.dirname(output_path), exist_ok=True)

# List of PDF files to analyze
pdf_files = [
    "27980427.pdf",
    "25653233.pdf",
    "23429291.pdf",
    "21088503.pdf",
    "32872376.pdf",
    "29626307.pdf"
]

print("Step 2: Extracting text from PDF files...")

def extract_text_from_pdf(pdf_path, max_pages=5):
    """Extract text from first few pages of PDF"""
    import pdfplumber
    text = ""
    try:
        with pdfplumber.open(pdf_path) as pdf:
            for i, page in enumerate(pdf.pages[:max_pages]):
                try:
                    page_text = page.extract_text()
                    if page_text:
                        text += f"\n--- Page {i+1} ---\n{page_text}"
                except:
                    continue
    except Exception as e:
        print(f"Error extracting from {pdf_path}: {e}")
    return text

# Extract and save text from each PDF
pdf_texts = {}
for pdf_file in pdf_files:
    pdf_path = os.path.join(pdf_dir, pdf_file)
    pmid = pdf_file.replace(".pdf", "")
    print(f"\nExtracting: {pdf_file}")
    
    text = extract_text_from_pdf(pdf_path)
    pdf_texts[pmid] = text
    
    # Save extracted text to temp file
    temp_file = os.path.join(tmp_dir, f"{pmid}.txt")
    with open(temp_file, 'w', encoding='utf-8') as f:
        f.write(text)
    
    # Print first 1000 characters for preview
    print(f"  Extracted {len(text)} characters")
    print(f"  Preview (first 1000 chars):")
    print(text[:1000])
    print("-" * 50)
</execute>
<observation>Step 2: Extracting text from PDF files...

Extracting: 27980427.pdf
  Extracted 23977 characters
  Preview (first 1000 chars):

--- Page 1 ---
Journal name: OncoTargets and Therapy
Article Designation: Original Research
Year: 2016
Volume: 9
OncoTargets and Therapy Dovepress Running head verso: Kang et al
Running head recto: Curcumin mediates chemosensitization to 5-FU
open access to scientific and medical research
DOI: http://dx.doi.org/10.2147/OTT.S118272
Open access Full Text article Original research
curcumin sensitizes human gastric cancer cells
to 5-fluorouracil through inhibition of the NFκB
survival-signaling pathway
Yanting Kang1,2,* Abstract: Fluorouracil (5-FU) is the most commonly used chemotherapeutic agent for gastric
Wanle hu3,* cancer (GC). However, the occurrence of resistance to 5-FU treatment poses a major problem
encheng Bai1,2 for its clinical efficacy. In this study, we found that the NFκB-signaling pathway can mediate
hailun Zheng1 5-FU resistance in GC cells. We developed a 5-FU-resistant GC cell line named SGCR/5-FU
Zhiguo liu1 and found that the 5-FU-induced resistance increased cytoso
--------------------------------------------------

Extracting: 25653233.pdf
  Extracted 21538 characters
  Preview (first 1000 chars):

--- Page 1 ---
Carcinogenesis, 2015, Vol. 36, No. 3, 355–367
doi:10.1093/carcin/bgv006
Advance Access publication February 4, 2015
Original Manuscript
original manuscript
Curcumin mediates chemosensitization to 5-fluorouracil
through miRNA-induced suppression of epithelial-
to-mesenchymal transition in chemoresistant
colorectal cancer
Shusuke Toden, Yoshinaga Okugawa, Thomas Jascur, Dominik Wodarz1,2,
Natalia L. Komarova1,2, Constanze Buhrmann3, Mehdi Shakibaei3,
C. Richard Boland and Ajay Goel*
Center for Gastrointestinal Research, and Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research
Institute and Sammons Cancer Center, Baylor University Medical Center, 3500 Gaston Avenue, Suite H-250, Dallas, TX 75246,
USA, 1Department of Ecology and Evolution and 2Department of Mathematics, University of California, Irvine, CA, USA and
3Institute of Anatomy, Ludwig-Maximilian University, Munich, Germany
*To whom correspondence should be addressed. Tel: +1 214 820 6852;
--------------------------------------------------

Extracting: 23429291.pdf
  Extracted 20070 characters
  Preview (first 1000 chars):

--- Page 1 ---
Citation:CellDeathandDisease(2013)4,e505;doi:10.1038/cddis.2013.26
&2013MacmillanPublishersLimited Allrightsreserved 2041-4889/13
www.nature.com/cddis
Mechanistic evaluation of the signaling events
regulating curcumin-mediated chemosensitization of
breast cancer cells to 5-fluorouracil
BSVinod1,2,JAntony1,2,HHNair1,VTPuliyappadamba1,MSaikia1,SShyamNarayanan1,ABevin1andRJohnAnto*,1
5-Fluorouracil(5-FU)isthefirstrationallydesignedantimetabolite,whichachievesitstherapeuticefficacythroughinhibitionof
theenzymethymidylatesynthase(TS),whichisessentialforthesynthesisandrepairofDNA.However,prolongedexposureto
5-FUinducesTSoverexpression,whichleadsto5-FUresistanceincancercells.Severalstudieshaveidentifiedcurcuminasa
potentchemosensitizeragainstchemoresistanceinducedbyvariouschemotherapeuticdrugs.Inthisstudy,wereportforthe
firsttime,withmechanism-basedevidences,thatcurcumincaneffectivelychemosensitizebreastcancercellsto5-FU,thereby
reducingthetoxicityanddrugresistance.Wefoundthat
--------------------------------------------------

Extracting: 21088503.pdf
  Extracted 23424 characters
  Preview (first 1000 chars):

--- Page 1 ---
RESEARCH PAPER RESEARCH PAPER
Cancer Biology & Therapy 11:2, 263-276; January 15, 2011; © 2011 Landes Bioscience
Anticancer activity of celastrol in combination
with ErbB2-targeted therapeutics for treatment
of ErbB2-overexpressing breast cancers
Srikumar M. Raja,1,4,* Robert J. Clubb,1,4,† Cesar Ortega-Cava,1,4 Stetson H. Williams,1 Tameka A. Bailey,1 Lei Duan,1,4,‡
Xiangshan Zhao,3,4 Alagarasamy L. Reddi,4,¥ Abijah M. Nyong,1 Amarnath Natarajan,1 Vimla Band1,3,4 and Hamid Band1-4,*
1Eppley Institute for Research in Cancer and Allied Diseases; 2Departments of Biochemistry and Molecular Biology, Pathology and Microbiology, and Pharmacology and
Neuroscience; and 3Genetics, Cell Biology and Anatomy; College of Medicine; University of Nebraska Medical Center; Omaha, NE USA
This work was initiated while the indicated authors were in the: 4Department of Medicine, Evanston Northwestern Healthcare Research Institute, Northwestern University,
Evanston, IL USA
Current address: †
--------------------------------------------------

Extracting: 32872376.pdf
  Extracted 15495 characters
  Preview (first 1000 chars):

--- Page 1 ---
nutrients
Article
Dietary Glycine Prevents FOLFOX
Chemotherapy-Induced Heart Injury: A Colorectal
Cancer Liver Metastasis Treatment Model in Rats
JusteManeikyte1,2,AugustinasBausys1,2,3,BettinaLeber1 ,NicoleFeldbacher1,
GeraldHoefler4,DagmarKolb-Lenz5,6,KestutisStrupas2,PhilippStiegler1and
PeterSchemmer1,*
1 General,VisceralandTransplantSurgery,DepartmentofSurgery,MedicalUniversityofGraz,
8036Graz,Austria;juste.maneikyte@gmail.com(J.M.);abpelikanas@gmail.com(A.B.);
bettina.leber@medunigraz.at(B.L.);Nicole.Feldbacher@medunigraz.at(N.F.);
philipp.stiegler@medunigraz.at(P.S.)
2 FacultyofMedicine,VilniusUniversity,03101Vilnius,Lithuania;kestutis.strupas@santa.lt
3 NationalCancerInstitute,08406Vilnius,Lithuania
4 DiagnosticandResearchInstituteofPathology,MedicalUniversityofGraz,8010Graz,Austria;
gerald.hoefler@medunigraz.at
5 InstituteofCellBiology,HistologyandEmbryology,MedicalUniversityGraz,8010Graz,Austria;
dagmar.kolb-lenz@medunigraz.at
6 CenterforMedicalResearch,CoreFac
--------------------------------------------------

Extracting: 29626307.pdf
  Extracted 17420 characters
  Preview (first 1000 chars):

--- Page 1 ---
HHS Public Access
Author manuscript
Ann Surg Oncol. Author manuscript; available in PMC 2019 June 01.
Published in final edited form as:
Ann Surg Oncol. 2018 June ; 25(6): 1709–1715. doi:10.1245/s10434-018-6468-8.
Preoperative fluorouracil, doxorubicin and streptozocin for the
treatment of pancreatic neuroendocrine liver metastases
Jordan M Cloyd, MD1,*, Kiyohiko Omichi, MD, PhD1,*, Takashi Mizuno, MD, PhD1, Yoshikuni
Kawaguchi, MD, PhD1, Ching-Wei D. Tzeng, MD1, Claudius Conrad, MD, PhD1, Yun Shin
Chun, MD1, Thomas A. Aloia, MD1, Matthew HG Katz, MD1, Jeffrey E Lee, MD1, Daniel
Halperin, MD2, James Yao, MD2, Jean-Nicolas Vauthey, MD1,*, and Arvind Dasari, MD2,*
1Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer
Center, Houston, TX, USA
Abstract
Introduction—While preoperative chemotherapy is frequently utilized prior to resection of non-
ne
--------------------------------------------------
</observation>
<execute>
# Now let me read the full text files to analyze each paper thoroughly
import os

tmp_dir = "/root/autodl-tmp/biomni_v20260208_tmp/kimi-k2.5/npcdr_extract_1/"

# Read all extracted texts
pdf_texts_full = {}
for pmid in ["27980427", "25653233", "23429291", "21088503", "32872376", "29626307"]:
    with open(os.path.join(tmp_dir, f"{pmid}.txt"), 'r', encoding='utf-8') as f:
        pdf_texts_full[pmid] = f.read()

print("Step 3: Analyzing each paper for classification...")

# Category definitions:
# Type 1: Enhancing drug efficacy by augmenting sensitivity and achieving synergy
# Type 2: Decreasing adverse drug reactions
# Type 3: Reversing drug resistance

analyses = {}

# Paper 1: 27980427
pmid = "27980427"
text = pdf_texts_full[pmid]
print(f"\n{'='*60}")
print(f"Paper: {pmid}")
print(f"{'='*60}")
print(text[:3000])
print("...")
print(text[-2000:])

print("\n--- ANALYSIS ---")
print("Title keywords: 'sensitizes', 'chemosensitization', '5-FU resistance'")
print("Key finding: Curcumin sensitizes gastric cancer cells to 5-FU by inhibiting NFκB pathway")
print("The paper specifically addresses overcoming 5-FU resistance in resistant cells")
print("CLASSIFICATION: Type 3 - Reversing drug resistance")
analyses[pmid] = 3
</execute>
<observation>Step 3: Analyzing each paper for classification...

============================================================
Paper: 27980427
============================================================

--- Page 1 ---
Journal name: OncoTargets and Therapy
Article Designation: Original Research
Year: 2016
Volume: 9
OncoTargets and Therapy Dovepress Running head verso: Kang et al
Running head recto: Curcumin mediates chemosensitization to 5-FU
open access to scientific and medical research
DOI: http://dx.doi.org/10.2147/OTT.S118272
Open access Full Text article Original research
curcumin sensitizes human gastric cancer cells
to 5-fluorouracil through inhibition of the NFκB
survival-signaling pathway
Yanting Kang1,2,* Abstract: Fluorouracil (5-FU) is the most commonly used chemotherapeutic agent for gastric
Wanle hu3,* cancer (GC). However, the occurrence of resistance to 5-FU treatment poses a major problem
encheng Bai1,2 for its clinical efficacy. In this study, we found that the NFκB-signaling pathway can mediate
hailun Zheng1 5-FU resistance in GC cells. We developed a 5-FU-resistant GC cell line named SGCR/5-FU
Zhiguo liu1 and found that the 5-FU-induced resistance increased cytosolic IκBα degradation and promoted
NFκB nuclear translocation in GC cells. These findings were further confirmed by the activation
Jianzhang Wu1
of the NFκB survival-signaling pathway in clinical specimens. Curcumin, a natural compound,
rong Jin2
can reverse 5-FU resistance and inhibits proliferation in GC cells by downregulating the NFκB-
chengguang Zhao1
signaling pathway. Moreover, it can also decrease the expression level of TNFα messenger RNA.
guang liang1
Flow cytometry and Western blot analysis results showed that the combination of curcumin and
1chemical Biology research center, 5-FU caused synergistic inhibition of growth and induction of potent apoptosis in the resistant
School of Pharmaceutical Sciences,
cancer cell lines in vitro. In conclusion, our results demonstrate that the combination of 5-FU
2Department of Epidemiology, First
Affiliated Hospital, 3Department of and curcumin could be further developed as a potential therapy for human GC.
Coloproctology, Second Affiliated Keywords: 5-FU, curcumin, NFκB, drug resistance, gastric cancer
hospital, Wenzhou Medical University,
Wenzhou, Zhejiang, china
Introduction
*These authors contributed equally
to this work Gastric cancer (GC) is the fourth most common type of cancer and the second high-
est cause of cancer-related death worldwide.1 Fluorouracil (5-FU) has been used as
the standard of care for advanced GC and has been found to increase overall survival
by 6% and reduce the risk of mortality by 18%.2 However, as most patients relapse
with lethal drug-resistant disease, the efficacy of 5-FU for GC is limited in clinical
treatment.3 To overcome 5-FU resistance, a combined therapy of docetaxel, cisplatin,
and 5-FU has been developed and has demonstrated improved efficacy, particularly
for advanced GC.4 However, it is very difficult to deal with intrinsic or acquired resis-
tance of certain tumors in 5-FU therapy. Furthermore, the increased toxicity of the
correspondence: chengguang Zhao; aforementioned com
...
(cid:38) (cid:53) (cid:21) (cid:42) (cid:38) (cid:53) (cid:20) (cid:53) (cid:21) (cid:53) (cid:22)
(cid:54) (cid:42) (cid:38) (cid:54) (cid:42) (cid:38) (cid:54) (cid:42) (cid:38) (cid:42) (cid:38) (cid:42) (cid:38) (cid:54) (cid:54) (cid:54) (cid:54) (cid:54)
(cid:42) (cid:54)(cid:42)(cid:38)(cid:53) (cid:43)
(cid:49)(cid:88)(cid:70)(cid:79)(cid:72)(cid:88)(cid:86) (cid:38)(cid:92)(cid:87)(cid:82)(cid:83)(cid:79)(cid:68)(cid:86)(cid:80)
(cid:54)(cid:42)(cid:38) (cid:54)(cid:42)(cid:38)(cid:53) (cid:54)(cid:42)(cid:38) (cid:54)(cid:42)(cid:38)(cid:53)
(cid:83)(cid:25)(cid:24) (cid:83)(cid:25)(cid:24)
(cid:47)(cid:68)(cid:80)(cid:76)(cid:81)(cid:3)(cid:37) (cid:42)(cid:36)(cid:51)(cid:39)(cid:43)
(cid:44) (cid:83)(cid:25)(cid:24)(cid:18)(cid:79)(cid:68)(cid:80)(cid:76)(cid:81)(cid:3)(cid:37)
(cid:21)
(cid:13)
(cid:20)(cid:17)(cid:24)
(cid:20)
(cid:19)(cid:17)(cid:24)
(cid:19)
(cid:54)(cid:42)(cid:38) (cid:54)(cid:42)(cid:38)(cid:53)
(cid:12)(cid:8)(cid:11)(cid:3)(cid:72)(cid:87)(cid:68)(cid:85)(cid:3)(cid:79)(cid:68)(cid:89)(cid:76)(cid:89)(cid:85)(cid:88)(cid:54)
(cid:92)(cid:87)(cid:76)(cid:86)(cid:81)(cid:72)(cid:87)(cid:81)(cid:76)(cid:3)(cid:72)(cid:89)(cid:76)(cid:87)(cid:68)(cid:79)(cid:72)(cid:53)
(cid:92)(cid:87)(cid:76)(cid:86)(cid:81)(cid:72)(cid:87)(cid:81)(cid:76)(cid:3)(cid:72)(cid:89)(cid:76)(cid:87)(cid:68)(cid:79)(cid:72)(cid:53)
(cid:92)(cid:87)(cid:76)(cid:86)(cid:81)(cid:72)(cid:87)(cid:81)(cid:76)(cid:3)(cid:72)(cid:89)(cid:76)(cid:87)(cid:68)(cid:79)(cid:72)(cid:53)
(cid:54)(cid:42)(cid:38)(cid:3)(cid:24)(cid:16)(cid:41)(cid:56)(cid:3)(cid:44)(cid:38) (cid:3)(cid:32)(cid:20)(cid:26)(cid:17)(cid:28)(cid:27)(cid:147)(cid:21)(cid:17)(cid:21)(cid:3)(cid:151)(cid:48)
(cid:24)(cid:19)
(cid:54)(cid:42)(cid:38)(cid:53)(cid:3)(cid:24)(cid:16)(cid:41)(cid:56)(cid:3)(cid:44)(cid:38) (cid:3)(cid:32)(cid:22)(cid:23)(cid:20)(cid:17)(cid:21)(cid:24)(cid:147)(cid:22)(cid:17)(cid:25)(cid:3)(cid:151)(cid:48)
(cid:24)(cid:19)
(cid:22) (cid:23)
Figure 1 (Continued)

--- ANALYSIS ---
Title keywords: 'sensitizes', 'chemosensitization', '5-FU resistance'
Key finding: Curcumin sensitizes gastric cancer cells to 5-FU by inhibiting NFκB pathway
The paper specifically addresses overcoming 5-FU resistance in resistant cells
CLASSIFICATION: Type 3 - Reversing drug resistance
</observation>
<execute>
# Paper 2: 25653233
pmid = "25653233"
text = pdf_texts_full[pmid]
print(f"\n{'='*60}")
print(f"Paper: {pmid}")
print(f"{'='*60}")
print(text[:3000])
print("...")
print(text[-1500:])

print("\n--- ANALYSIS ---")
print("Title: 'Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer'")
print("Key phrases: 'chemosensitization', 'chemoresistant colorectal cancer'")
print("The paper focuses on sensitizing chemoresistant cancer cells to 5-FU")
print("CLASSIFICATION: Type 3 - Reversing drug resistance")
analyses[pmid] = 3
</execute>
<observation>NameError("name 'pdf_texts_full' is not defined")</observation>
<execute>
import os
import json
import re

# Paths
pdf_dir = "/root/biodatalab/benchmark/dataset/NPCDR"
tmp_dir = "/root/autodl-tmp/biomni_v20260208_tmp/kimi-k2.5/npcdr_extract_1/"
output_path = "/root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json"

os.makedirs(tmp_dir, exist_ok=True)
os.makedirs(os.path.dirname(output_path), exist_ok=True)

pdf_files = [
    "27980427.pdf",
    "25653233.pdf",
    "23429291.pdf",
    "21088503.pdf",
    "32872376.pdf",
    "29626307.pdf"
]

# Read all extracted texts
pdf_texts_full = {}
for pmid in ["27980427", "25653233", "23429291", "21088503", "32872376", "29626307"]:
    txt_path = os.path.join(tmp_dir, f"{pmid}.txt")
    if os.path.exists(txt_path):
        with open(txt_path, 'r', encoding='utf-8') as f:
            pdf_texts_full[pmid] = f.read()
    else:
        # Extract if not exists
        import pdfplumber
        pdf_path = os.path.join(pdf_dir, f"{pmid}.pdf")
        text = ""
        with pdfplumber.open(pdf_path) as pdf:
            for i, page in enumerate(pdf.pages[:5]):
                try:
                    page_text = page.extract_text()
                    if page_text:
                        text += f"\n--- Page {i+1} ---\n{page_text}"
                except:
                    continue
        with open(txt_path, 'w', encoding='utf-8') as f:
            f.write(text)
        pdf_texts_full[pmid] = text

analyses = {}

# Paper 1: 27980427 - Already determined
analyses["27980427"] = 3  # Reversing drug resistance

# Paper 2: 25653233
pmid = "25653233"
text = pdf_texts_full[pmid]
print(f"\n{'='*60}")
print(f"Paper: {pmid}")
print(f"{'='*60}")
print(text[:2500])
</execute>
<observation>
============================================================
Paper: 25653233
============================================================

--- Page 1 ---
Carcinogenesis, 2015, Vol. 36, No. 3, 355–367
doi:10.1093/carcin/bgv006
Advance Access publication February 4, 2015
Original Manuscript
original manuscript
Curcumin mediates chemosensitization to 5-fluorouracil
through miRNA-induced suppression of epithelial-
to-mesenchymal transition in chemoresistant
colorectal cancer
Shusuke Toden, Yoshinaga Okugawa, Thomas Jascur, Dominik Wodarz1,2,
Natalia L. Komarova1,2, Constanze Buhrmann3, Mehdi Shakibaei3,
C. Richard Boland and Ajay Goel*
Center for Gastrointestinal Research, and Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research
Institute and Sammons Cancer Center, Baylor University Medical Center, 3500 Gaston Avenue, Suite H-250, Dallas, TX 75246,
USA, 1Department of Ecology and Evolution and 2Department of Mathematics, University of California, Irvine, CA, USA and
3Institute of Anatomy, Ludwig-Maximilian University, Munich, Germany
*To whom correspondence should be addressed. Tel: +1 214 820 6852; Fax: +1 214 818 9292; Email: ajay.goel@baylorhealth.edu
Abstract
Resistance to cytotoxic chemotherapy is a major cause of mortality in colorectal cancer (CRC) patients. Chemoresistance
has been linked primarily to a subset of cancer cells undergoing epithelial–mesenchymal transition (EMT). Curcumin, a
botanical with antitumorigenic properties, has been shown to enhance sensitivity of cancer cells to chemotherapeutic
drugs, but the molecular mechanisms underlying this phenomenon remain unclear. Effects of curcumin and 5-fluorouracil
(5FU) individually, and in combination, were examined in parental and 5FU resistant (5FUR) cell lines. We performed a
series of growth proliferation and apoptosis assays in 2D and 3D cell cultures. Furthermore, we identified and analyzed
the expression pattern of a subset of putative EMT-suppressive microRNAs (miRNAs) and their downstream target genes
regulated by curcumin. Chemosensitizing effects of curcumin were validated in a xenograft mouse model. Combined
treatment with curcumin and 5FU enhanced cellular apoptosis and inhibited proliferation in both parental and 5FUR
cells, whereas 5FU alone was ineffective in 5FUR cells. A group of EMT-suppressive miRNAs were upregulated by curcumin
treatment in 5FUR cells. Curcumin suppressed EMT in 5FUR cells by downregulating BMI1, SUZ12 and EZH2 transcripts,
key mediators of cancer stemness-related polycomb repressive complex subunits. Using a xenograft and mathematical
models, we further demonstrated t
</observation>
<execute>
print("--- ANALYSIS for 25653233 ---")
print("Title: 'Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer'")
print("Key phrases: 'chemosensitization', 'chemoresistant colorectal cancer', '5FU resistant (5FUR) cell lines'")
print("Focus: Overcoming resistance to 5-FU in colorectal cancer")
print("CLASSIFICATION: Type 3 - Reversing drug resistance")
analyses["25653233"] = 3

# Paper 3: 23429291
pmid = "23429291"
text = pdf_texts_full[pmid]
print(f"\n{'='*60}")
print(f"Paper: {pmid}")
print(f"{'='*60}")
print(text[:2500])
</execute>
<observation>NameError("name 'analyses' is not defined")</observation>
<execute>
import os
import json
import re
import pdfplumber

# Paths
pdf_dir = "/root/biodatalab/benchmark/dataset/NPCDR"
tmp_dir = "/root/autodl-tmp/biomni_v20260208_tmp/kimi-k2.5/npcdr_extract_1/"
output_path = "/root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json"

os.makedirs(tmp_dir, exist_ok=True)
os.makedirs(os.path.dirname(output_path), exist_ok=True)

pmids = ["27980427", "25653233", "23429291", "21088503", "32872376", "29626307"]

# Read all extracted texts
pdf_texts_full = {}
for pmid in pmids:
    txt_path = os.path.join(tmp_dir, f"{pmid}.txt")
    if os.path.exists(txt_path):
        with open(txt_path, 'r', encoding='utf-8') as f:
            pdf_texts_full[pmid] = f.read()

analyses = {}

# Paper 1: 27980427
print("="*60)
print("Paper: 27980427")
print("="*60)
print("Title: Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway")
print("Key findings: Developed 5-FU-resistant GC cell line; curcumin reverses 5-FU resistance")
print("CLASSIFICATION: Type 3 - Reversing drug resistance")
analyses["27980427"] = 3

# Paper 2: 25653233
print("\n" + "="*60)
print("Paper: 25653233")
print("="*60)
print("Title: Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer")
print("Key findings: Focus on 5FU resistant (5FUR) cells; overcoming chemoresistance")
print("CLASSIFICATION: Type 3 - Reversing drug resistance")
analyses["25653233"] = 3

# Paper 3: 23429291
pmid = "23429291"
text = pdf_texts_full[pmid]
print("\n" + "="*60)
print(f"Paper: {pmid}")
print("="*60)
print(text[:2500])
</execute>
<observation>============================================================
Paper: 27980427
============================================================
Title: Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway
Key findings: Developed 5-FU-resistant GC cell line; curcumin reverses 5-FU resistance
CLASSIFICATION: Type 3 - Reversing drug resistance

============================================================
Paper: 25653233
============================================================
Title: Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer
Key findings: Focus on 5FU resistant (5FUR) cells; overcoming chemoresistance
CLASSIFICATION: Type 3 - Reversing drug resistance

============================================================
Paper: 23429291
============================================================

--- Page 1 ---
Citation:CellDeathandDisease(2013)4,e505;doi:10.1038/cddis.2013.26
&2013MacmillanPublishersLimited Allrightsreserved 2041-4889/13
www.nature.com/cddis
Mechanistic evaluation of the signaling events
regulating curcumin-mediated chemosensitization of
breast cancer cells to 5-fluorouracil
BSVinod1,2,JAntony1,2,HHNair1,VTPuliyappadamba1,MSaikia1,SShyamNarayanan1,ABevin1andRJohnAnto*,1
5-Fluorouracil(5-FU)isthefirstrationallydesignedantimetabolite,whichachievesitstherapeuticefficacythroughinhibitionof
theenzymethymidylatesynthase(TS),whichisessentialforthesynthesisandrepairofDNA.However,prolongedexposureto
5-FUinducesTSoverexpression,whichleadsto5-FUresistanceincancercells.Severalstudieshaveidentifiedcurcuminasa
potentchemosensitizeragainstchemoresistanceinducedbyvariouschemotherapeuticdrugs.Inthisstudy,wereportforthe
firsttime,withmechanism-basedevidences,thatcurcumincaneffectivelychemosensitizebreastcancercellsto5-FU,thereby
reducingthetoxicityanddrugresistance.Wefoundthat10lM5-FUand10lMcurcumininducesasynergisticcytotoxiceffectin
differentbreastcancercells,independentoftheirreceptorstatus,throughtheenhancementofapoptosis.Curcuminwasfound
to sensitize the breast cancer cells to 5-FU through TS-dependent downregulation of nuclear factor-jB (NF-jB), and this
observation was confirmed by silencing TS and inactivating NF-jB, both of which reduced the chemosensitizing efficacy of
curcumin.SilencingofTSsuppressed5-FU-inducedNF-jBactivation,whereasinactivationofNF-jBdidnotaffect5-FU-induced
TS upregulation, confirming that TS is upstream of NF-jB and regulates the activation of NF-jB in 5-FU-induced signaling
pathway.AlthoughAkt/PI3kinaseandmitogen-activatedproteinkinasepathwaysareactivatedby5-FUanddownregulatedby
curcumin,theydonothaveanyroleinregulatingthesynergism.Ascurcuminisapharmacologicallysafeandcost-effective
compound,itsuseincombinationwith5-FUmayimprovethetherapeuticindexof5-FU,ifcorroboratedbyinvivostudiesand
clinicaltrials.
CellDeathandDisease(2013)4,e505;doi:10.1038/cddis.2013.26;publishedonline21February2013
SubjectCategory:Cancer
Eradicationofbreastcanceriscurrentlyademandingarena types of cancers including breast cancer.4 It inhibits cancer
owingtothechallengesfacedindevelopinganadequatedrug cell growth and initiates apoptosis by targeting thymidylate
for its treatment because of the heterogeneity in receptor synthase(TS),anenzymecrucialforthedenovosynthesisof
status of breast cancer tissues. Drugs for breast cancer DNA,5andalsobyind
</observation>
<execute>
print("--- ANALYSIS for 23429291 ---")
print("Title: Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil")
print("Key phrases: 'chemosensitize', 'reducing the toxicity and drug resistance', 'potent chemosensitizer against chemoresistance'")
print("Focus: Reversing 5-FU resistance through curcumin")
print("CLASSIFICATION: Type 3 - Reversing drug resistance")
analyses["23429291"] = 3

# Paper 4: 21088503
pmid = "21088503"
text = pdf_texts_full[pmid]
print("\n" + "="*60)
print(f"Paper: {pmid}")
print("="*60)
print(text[:2500])
</execute>
<observation>NameError("name 'analyses' is not defined")</observation>
<execute>
import os
import json
import re
import pdfplumber

# Paths
pdf_dir = "/root/biodatalab/benchmark/dataset/NPCDR"
tmp_dir = "/root/autodl-tmp/biomni_v20260208_tmp/kimi-k2.5/npcdr_extract_1/"
output_path = "/root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json"

os.makedirs(tmp_dir, exist_ok=True)
os.makedirs(os.path.dirname(output_path), exist_ok=True)

pmids = ["27980427", "25653233", "23429291", "21088503", "32872376", "29626307"]

# Read all extracted texts
pdf_texts_full = {}
for pmid in pmids:
    txt_path = os.path.join(tmp_dir, f"{pmid}.txt")
    if os.path.exists(txt_path):
        with open(txt_path, 'r', encoding='utf-8') as f:
            pdf_texts_full[pmid] = f.read()

# Store all analyses
analyses = {}

# Paper 1: 27980427
analyses["27980427"] = 3  # Reversing drug resistance
print("Paper 27980427: Type 3 (Reversing drug resistance)")

# Paper 2: 25653233
analyses["25653233"] = 3  # Reversing drug resistance
print("Paper 25653233: Type 3 (Reversing drug resistance)")

# Paper 3: 23429291
analyses["23429291"] = 3  # Reversing drug resistance
print("Paper 23429291: Type 3 (Reversing drug resistance)")

# Paper 4: 21088503
pmid = "21088503"
text = pdf_texts_full[pmid]
print("\n" + "="*60)
print(f"Paper: {pmid}")
print("="*60)
print(text[:2500])
print("\n...")
print(text[-1500:])
</execute>
<observation>Paper 27980427: Type 3 (Reversing drug resistance)
Paper 25653233: Type 3 (Reversing drug resistance)
Paper 23429291: Type 3 (Reversing drug resistance)

============================================================
Paper: 21088503
============================================================

--- Page 1 ---
RESEARCH PAPER RESEARCH PAPER
Cancer Biology & Therapy 11:2, 263-276; January 15, 2011; © 2011 Landes Bioscience
Anticancer activity of celastrol in combination
with ErbB2-targeted therapeutics for treatment
of ErbB2-overexpressing breast cancers
Srikumar M. Raja,1,4,* Robert J. Clubb,1,4,† Cesar Ortega-Cava,1,4 Stetson H. Williams,1 Tameka A. Bailey,1 Lei Duan,1,4,‡
Xiangshan Zhao,3,4 Alagarasamy L. Reddi,4,¥ Abijah M. Nyong,1 Amarnath Natarajan,1 Vimla Band1,3,4 and Hamid Band1-4,*
1Eppley Institute for Research in Cancer and Allied Diseases; 2Departments of Biochemistry and Molecular Biology, Pathology and Microbiology, and Pharmacology and
Neuroscience; and 3Genetics, Cell Biology and Anatomy; College of Medicine; University of Nebraska Medical Center; Omaha, NE USA
This work was initiated while the indicated authors were in the: 4Department of Medicine, Evanston Northwestern Healthcare Research Institute, Northwestern University,
Evanston, IL USA
Current address: †Genzyme Genetics; Westborough, MA USA; ‡Rush University Medical Center; Chicago, IL USA; ¥Department of Medicine; Northwestern University;
Chicago, IL USA
Key words: ErbB2, Her2/Neu, 17-AAG, celastrol, trastuzumab, targeted therapy, drug interaction, ubiquitin, proteasome,
HSP90, ROS
Abbreviations: AR, androgen receptor; 17-AAG, 17-(allylamino)-17-demethoxygeldanamycin; CI, combination index; CIM,
confocal immunofluorescence microscopy; CM-H DCFDA, 5-(and-6)-chloromethyl-2'-7'-dichlorodihydrofluorescein diacetate,
2
acetyl ester; DAPI, 4', 6-diamidino-2-phenylindole; DTT, dithiothreitol; ErbB2 or Her2, epidermal growth factor receptor B2 or
human epidermal growth factor receptor 2; Her3, human epidermal growth factor receptor 3; EGF, epidermal growth factor; EGFR,
epidermal growth factor receptor; ER, endoplasmic reticulum; FACS, fluorescence activated cell sorter; GA, geldanamycin; GSH,
reduced glutathione; HSP90, heat shock protein 90; Hsc70, heat shock cognate 70; IKK, Ikappa B kinase; IP, immunoprecipitation;
IF, immunofluorescence; IB, immunoblotting; MEM, minimal essential media; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromide; NFκB, nuclear factor kappaB; LAMP-1, lysosome associated membrane protein-1; PEITC, phenyl
ethyl isothiocyanate; PFA, paraformaldehyde; PI3K, phospho-inositide-3-kinase; PTEN, phosphatase and tensin homolog deleted
on chromosome ten; ROS, reactive oxygen species; RTK, receptor tyrosine kinase; SDS-PAGE/WB, sodium dodecylsulfate


...
ess the cytotoxicity of Celastrol (Fig. 1 and associated
compare lane 3 with 7 and lane 4 with 8). The lower levels of table), indicated higher levels of basal ROS (Fig. 9C) in cell lines
266 Cancer Biology & Therapy Volume 11 Issue 2
--- Page 5 ---
Figure 3. Celastrol in combination with ErbB2-targeted drugs, Trastuzumab and Lapatinib, synergistically induces cytotoxicity ErbB2-overexpressing
breast cancer cells: SKBr-3 cells were treated with Celastrol as a single drug or in combination with Trastuzumab or Lapatinib as described in the meth-
ods section. The viable cells at the end of treatment were assessed using the MTT dye assay and data represented as % of vehicle control. Shown here
is the comparison of cytotoxicity of single drug treatments or combination with Trastuzumab (A) or Lapatinib (C), showing efficacy of combinatorial
treatment over single drugs. (A) The IC for Celastrol alone was 0.13 ± 0.02 μM; whereas it was 0.0027 ± 0.001 μM when combined with Trastuzumab at
50
1 μg/ml. The % cell viability for SKBr-3 treated with Trastuzumab alone at this concentration was 51.4 ± 7.7. (C) The IC for Lapatinib was 25.5 ± 2.1 nM
50
as a single drug versus 3.5 ± 1.6 nM when combined with Celastrol. Also shown are Chou-Talalay analyses for Celastrol plus Trastuzumab (B) or Celas-
trol plus Lapatinib (D) combination. Combination index (CI) <1 indicates synergy; CI ~ 1 indicates additive effects; CI >1 indicates antagonism.
www.landesbioscience.com Cancer Biology & Therapy 267
</observation>
<execute>
print("--- ANALYSIS for 21088503 ---")
print("Title: Anticancer activity of celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers")
print("Key phrases: 'synergistically induces cytotoxicity', 'CI < 1 indicates synergy'")
print("Focus: Celastrol combines with trastuzumab/lapatinib to achieve synergistic cytotoxicity")
print("The paper emphasizes synergy (CI < 1) and enhanced efficacy, not resistance reversal")
print("CLASSIFICATION: Type 1 - Enhancing drug efficacy by augmenting sensitivity and achieving synergy")
analyses["21088503"] = 1

# Paper 5: 32872376
pmid = "32872376"
text = pdf_texts_full[pmid]
print("\n" + "="*60)
print(f"Paper: {pmid}")
print("="*60)
print(text[:2500])
</execute>
<observation>NameError("name 'analyses' is not defined")</observation>
<execute>
import os
import json
import re
import pdfplumber

# Paths
pdf_dir = "/root/biodatalab/benchmark/dataset/NPCDR"
tmp_dir = "/root/autodl-tmp/biomni_v20260208_tmp/kimi-k2.5/npcdr_extract_1/"
output_path = "/root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json"

os.makedirs(tmp_dir, exist_ok=True)
os.makedirs(os.path.dirname(output_path), exist_ok=True)

pmids = ["27980427", "25653233", "23429291", "21088503", "32872376", "29626307"]

# Read all extracted texts
pdf_texts_full = {}
for pmid in pmids:
    txt_path = os.path.join(tmp_dir, f"{pmid}.txt")
    with open(txt_path, 'r', encoding='utf-8') as f:
        pdf_texts_full[pmid] = f.read()

# Store all analyses
analyses = {}

print("="*60)
print("ANALYSIS OF ALL PAPERS")
print("="*60)

# Paper 1: 27980427
analyses["27980427"] = 3
print("\nPaper 27980427: Type 3 (Reversing drug resistance)")
print("  - Focus: Reversing 5-FU resistance in gastric cancer")

# Paper 2: 25653233
analyses["25653233"] = 3
print("\nPaper 25653233: Type 3 (Reversing drug resistance)")
print("  - Focus: Chemosensitization of 5FU-resistant colorectal cancer")

# Paper 3: 23429291
analyses["23429291"] = 3
print("\nPaper 23429291: Type 3 (Reversing drug resistance)")
print("  - Focus: Chemosensitization against 5-FU resistance in breast cancer")

# Paper 4: 21088503
analyses["21088503"] = 1
print("\nPaper 21088503: Type 1 (Enhancing drug efficacy/synergy)")
print("  - Focus: Celastrol + trastuzumab/lapatinib synergy")

# Paper 5: 32872376
pmid = "32872376"
text = pdf_texts_full[pmid]
print("\n" + "="*60)
print(f"Paper: {pmid}")
print("="*60)
print(text[:2000])
</execute>
<observation>============================================================
ANALYSIS OF ALL PAPERS
============================================================

Paper 27980427: Type 3 (Reversing drug resistance)
  - Focus: Reversing 5-FU resistance in gastric cancer

Paper 25653233: Type 3 (Reversing drug resistance)
  - Focus: Chemosensitization of 5FU-resistant colorectal cancer

Paper 23429291: Type 3 (Reversing drug resistance)
  - Focus: Chemosensitization against 5-FU resistance in breast cancer

Paper 21088503: Type 1 (Enhancing drug efficacy/synergy)
  - Focus: Celastrol + trastuzumab/lapatinib synergy

============================================================
Paper: 32872376
============================================================

--- Page 1 ---
nutrients
Article
Dietary Glycine Prevents FOLFOX
Chemotherapy-Induced Heart Injury: A Colorectal
Cancer Liver Metastasis Treatment Model in Rats
JusteManeikyte1,2,AugustinasBausys1,2,3,BettinaLeber1 ,NicoleFeldbacher1,
GeraldHoefler4,DagmarKolb-Lenz5,6,KestutisStrupas2,PhilippStiegler1and
PeterSchemmer1,*
1 General,VisceralandTransplantSurgery,DepartmentofSurgery,MedicalUniversityofGraz,
8036Graz,Austria;juste.maneikyte@gmail.com(J.M.);abpelikanas@gmail.com(A.B.);
bettina.leber@medunigraz.at(B.L.);Nicole.Feldbacher@medunigraz.at(N.F.);
philipp.stiegler@medunigraz.at(P.S.)
2 FacultyofMedicine,VilniusUniversity,03101Vilnius,Lithuania;kestutis.strupas@santa.lt
3 NationalCancerInstitute,08406Vilnius,Lithuania
4 DiagnosticandResearchInstituteofPathology,MedicalUniversityofGraz,8010Graz,Austria;
gerald.hoefler@medunigraz.at
5 InstituteofCellBiology,HistologyandEmbryology,MedicalUniversityGraz,8010Graz,Austria;
dagmar.kolb-lenz@medunigraz.at
6 CenterforMedicalResearch,CoreFacilityUltrastructureAnalysis,MedicalUniversityGraz,
8010Graz,Austria
* Correspondence: peter.schemmer@medunigraz.at;Tel.:+43-316-385-84094
(cid:1)(cid:2)(cid:3)(cid:1)(cid:4)(cid:5)(cid:6)(cid:7)(cid:8)(cid:1)
(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:7)
Received: 8June2020;Accepted: 26August2020;Published: 28August2020
Abstract: Introduction: FOLFOX chemotherapy (CTx) is used for the treatment of colorectal liver
metastasis(CRLM).Sideeffectsincluderarecardiotoxicity,whichmaylimittheapplicationofFOLFOX.
Currently,thereisnoeffectivestrategytopreventFOLFOX-inducedcardiotoxicity. Glycinehasbeen
showntoprotectliversfromCTx-inducedinjuryandoxidativestress,anditreducesplateletaggregation
andimprovesmicroperfusion. Thisstudytestedthehypothesisofglycinebeingcardioprotectivein
aratmodelofFOLFOXincombinationwithCRLM.MaterialsandMethods: Theeffectofglycine
wastestedinvitroonhumancardiacmyocytes(HCMs). TotestglycineinvivoWag/Rijratswith
inducedCRLMweretreatedwithFOLFOX±5%dietaryglycine. Leftve
</observation>
<execute>
print("--- ANALYSIS for 32872376 ---")
print("Title: Dietary Glycine Prevents FOLFOX Chemotherapy-Induced Heart Injury")
print("Key phrases: 'Prevents FOLFOX Chemotherapy-Induced Heart Injury', 'cardiotoxicity', 'cardioprotective'")
print("Focus: Protecting against chemotherapy-induced cardiac toxicity")
print("CLASSIFICATION: Type 2 - Decreasing adverse drug reactions")
analyses["32872376"] = 2

# Paper 6: 29626307
pmid = "29626307"
text = pdf_texts_full[pmid]
print("\n" + "="*60)
print(f"Paper: {pmid}")
print("="*60)
print(text[:2500])
print("...")
print(text[-1500:])
</execute>
<observation>NameError("name 'analyses' is not defined")</observation>
<execute>
import os
import json
import re
import pdfplumber

# Paths
pdf_dir = "/root/biodatalab/benchmark/dataset/NPCDR"
tmp_dir = "/root/autodl-tmp/biomni_v20260208_tmp/kimi-k2.5/npcdr_extract_1/"
output_path = "/root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json"

os.makedirs(tmp_dir, exist_ok=True)
os.makedirs(os.path.dirname(output_path), exist_ok=True)

pmids = ["27980427", "25653233", "23429291", "21088503", "32872376", "29626307"]

# Read all extracted texts
pdf_texts_full = {}
for pmid in pmids:
    txt_path = os.path.join(tmp_dir, f"{pmid}.txt")
    with open(txt_path, 'r', encoding='utf-8') as f:
        pdf_texts_full[pmid] = f.read()

# Store all analyses
analyses = {}

print("="*60)
print("ANALYSIS OF ALL PAPERS")
print("="*60)

# Paper 1: 27980427
analyses["27980427"] = 3
print("\nPaper 27980427: Type 3 (Reversing drug resistance)")
print("  - Title: Curcumin sensitizes human gastric cancer cells to 5-FU")
print("  - Focus: Reversing 5-FU resistance in gastric cancer")

# Paper 2: 25653233
analyses["25653233"] = 3
print("\nPaper 25653233: Type 3 (Reversing drug resistance)")
print("  - Title: Curcumin mediates chemosensitization to 5-FU in chemoresistant colorectal cancer")
print("  - Focus: Chemosensitization of 5FU-resistant colorectal cancer")

# Paper 3: 23429291
analyses["23429291"] = 3
print("\nPaper 23429291: Type 3 (Reversing drug resistance)")
print("  - Title: Curcumin-mediated chemosensitization of breast cancer cells to 5-FU")
print("  - Focus: Chemosensitization against 5-FU resistance in breast cancer")

# Paper 4: 21088503
analyses["21088503"] = 1
print("\nPaper 21088503: Type 1 (Enhancing drug efficacy/synergy)")
print("  - Title: Celastrol in combination with ErbB2-targeted therapeutics")
print("  - Focus: Celastrol + trastuzumab/lapatinib synergy (CI < 1)")

# Paper 5: 32872376
analyses["32872376"] = 2
print("\nPaper 32872376: Type 2 (Decreasing adverse drug reactions)")
print("  - Title: Dietary Glycine Prevents FOLFOX Chemotherapy-Induced Heart Injury")
print("  - Focus: Preventing cardiotoxicity side effects")

# Paper 6: 29626307
pmid = "29626307"
text = pdf_texts_full[pmid]
print("\n" + "="*60)
print(f"Paper: {pmid}")
print("="*60)
print(text[:2500])
print("...")
print(text[-1500:])

print("\n--- ANALYSIS for 29626307 ---")
print("Title: Preoperative fluorouracil, doxorubicin and streptozocin for the treatment of pancreatic neuroendocrine liver metastases")
print("Key findings: This appears to be about chemotherapy regimen efficacy in treating cancer")
print("Looking for the primary therapeutic effect...")
</execute>
<observation>============================================================
ANALYSIS OF ALL PAPERS
============================================================

Paper 27980427: Type 3 (Reversing drug resistance)
  - Title: Curcumin sensitizes human gastric cancer cells to 5-FU
  - Focus: Reversing 5-FU resistance in gastric cancer

Paper 25653233: Type 3 (Reversing drug resistance)
  - Title: Curcumin mediates chemosensitization to 5-FU in chemoresistant colorectal cancer
  - Focus: Chemosensitization of 5FU-resistant colorectal cancer

Paper 23429291: Type 3 (Reversing drug resistance)
  - Title: Curcumin-mediated chemosensitization of breast cancer cells to 5-FU
  - Focus: Chemosensitization against 5-FU resistance in breast cancer

Paper 21088503: Type 1 (Enhancing drug efficacy/synergy)
  - Title: Celastrol in combination with ErbB2-targeted therapeutics
  - Focus: Celastrol + trastuzumab/lapatinib synergy (CI < 1)

Paper 32872376: Type 2 (Decreasing adverse drug reactions)
  - Title: Dietary Glycine Prevents FOLFOX Chemotherapy-Induced Heart Injury
  - Focus: Preventing cardiotoxicity side effects

============================================================
Paper: 29626307
============================================================

--- Page 1 ---
HHS Public Access
Author manuscript
Ann Surg Oncol. Author manuscript; available in PMC 2019 June 01.
Published in final edited form as:
Ann Surg Oncol. 2018 June ; 25(6): 1709–1715. doi:10.1245/s10434-018-6468-8.
Preoperative fluorouracil, doxorubicin and streptozocin for the
treatment of pancreatic neuroendocrine liver metastases
Jordan M Cloyd, MD1,*, Kiyohiko Omichi, MD, PhD1,*, Takashi Mizuno, MD, PhD1, Yoshikuni
Kawaguchi, MD, PhD1, Ching-Wei D. Tzeng, MD1, Claudius Conrad, MD, PhD1, Yun Shin
Chun, MD1, Thomas A. Aloia, MD1, Matthew HG Katz, MD1, Jeffrey E Lee, MD1, Daniel
Halperin, MD2, James Yao, MD2, Jean-Nicolas Vauthey, MD1,*, and Arvind Dasari, MD2,*
1Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer
Center, Houston, TX, USA
Abstract
Introduction—While preoperative chemotherapy is frequently utilized prior to resection of non-
neuroendocrine liver metastases, patients with resectable neuroendocrine liver metastases typically
undergo surgery first. FAS is a cytotoxic chemotherapy regimen that is associated with substantial
response rates in locally advanced and metastatic pancreatic neuroendocrine tumors.
Methods—All patients who underwent R0/R1 resection of pancreatic neuroendocrine liver
metastases at a single institution between 1998 and 2015 were included. The outcomes of patients
treated with preoperative FAS were compared to those of patients who were not.
Results—Of the 67 patients included, 27 (40.3%) received preoperative FAS while 40 (59.7%)
did not. Despite being associated with higher rates of synchronous disease, lymph node
metastases, and larger tumor size, patients who received preoperative FAS had similar overall
survival (OS, 108.2 months [95% CI 78.0-136.0] vs 107.0 months [95% CI 78.0-136.0], p=0.64)
and recurrence-free survival (RFS, 25.1 months [95% CI 23.2-27.0] vs 18.0 months [95% CI
13.8-22.2], p=0.16) as patients who did not. Among patients who presented with synchronous liver
metastases (n=46), the median OS (97.3 months [95% CI 65.9-128.6] vs 65.0 months [95% CI
28.1-101.9], p=0.001) and RFS (24.8 months [95% CI 22.6-26.9] vs 12.1 months [2.2-22.0],
p=0.003) were significantly greater among patients who received preoperative FAS compared to
those who did not.
Conclusions—The use of FAS prior to liver resection is associated with improved OS compared
to surgery alone among pa
...
vailable on effective neoadjuvant treatment strategies for patients with NELM. To
that end, our study, albeit retrospective, represents one of the first to demonstrate the
potential efficacy of a preoperative regimen for patients with potentially resectable
pancreatic NELM who present with advanced disease. Specifically, our study has several
pertinent findings. First, among patients included in this retrospective study who underwent
resection, the response rate of pancreatic NELM to FAS was approximately 63%. Second,
despite more aggressive clinical and biological characteristics, patients who underwent FAS
prior to surgical resection had similar OS and RFS compared to patients who underwent
surgery first without any increase in the incidence of major post-operative complications.
Third, among patients with synchronous liver metastases, preoperative FAS was associated
with a significant OS and RFS survival benefit. Finally, when compared to patients treated
with FAS alone for potentially resectable liver metastases, those who underwent liver
resection after FAS had significantly better OS.
The combination of streptozocin with doxorubicin is a common therapeutic regimen for
patients with metastatic or advanced pNET based on the results of a series of randomized
controlled trials from the Eastern Cooperative Oncology Group11,12. However, our
Ann Surg Oncol. Author manuscript; available in PMC 2019 June 01.
Author
Manuscript
Author
Manuscript
Author
Manuscript
Author
Manuscript

--- ANALYSIS for 29626307 ---
Title: Preoperative fluorouracil, doxorubicin and streptozocin for the treatment of pancreatic neuroendocrine liver metastases
Key findings: This appears to be about chemotherapy regimen efficacy in treating cancer
Looking for the primary therapeutic effect...
</observation>
<execute>
# Analyzing 29626307 in more detail
pmid = "29626307"
text = pdf_texts_full[pmid]

print("--- DETAILED ANALYSIS for 29626307 ---")
print("Title: Preoperative fluorouracil, doxorubicin and streptozocin for the treatment of pancreatic neuroendocrine liver metastases")
print("\nKey findings from the paper:")
print("- Streptozocin is a natural product (antibiotic derived from Streptomyces)")
print("- FAS = Fluorouracil + Doxorubicin + Streptozocin combination")
print("- Study compares preoperative FAS vs no FAS treatment")
print("- Preoperative FAS improved OS (97.3 vs 65.0 months) and RFS (24.8 vs 12.1 months)")
print("- Focus: Efficacy of combination chemotherapy regimen")
print("\nThe paper is about the efficacy of the FAS combination therapy in treating cancer.")
print("This is NOT about reversing resistance (no mention of resistant cells).")
print("This is NOT about decreasing adverse reactions (though it mentions no increase in complications).")
print("This IS about achieving better treatment outcomes through combination therapy efficacy.")
print("\nCLASSIFICATION: Type 1 - Enhancing drug efficacy by augmenting sensitivity and achieving synergy")

analyses["29626307"] = 1

print("\n" + "="*60)
print("FINAL CLASSIFICATION SUMMARY")
print("="*60)

type_descriptions = {
    1: "Enhancing drug efficacy by augmenting sensitivity and achieving synergy",
    2: "Decreasing adverse drug reactions",
    3: "Reversing drug resistance"
}

for pmid in ["27980427", "25653233", "23429291", "21088503", "32872376", "29626307"]:
    type_id = analyses[pmid]
    print(f"  {pmid}: Type {type_id} - {type_descriptions[type_id]}")
</execute>
<observation>NameError("name 'pdf_texts_full' is not defined")</observation>
<execute>
import os
import json

# Paths
output_path = "/root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json"
os.makedirs(os.path.dirname(output_path), exist_ok=True)

# Final classifications based on detailed analysis
results = [
    {"PMID": "27980427", "TypeID": 3},  # Reversing drug resistance - Curcumin reverses 5-FU resistance
    {"PMID": "25653233", "TypeID": 3},  # Reversing drug resistance - Curcumin chemosensitization of 5FU-resistant cells
    {"PMID": "23429291", "TypeID": 3},  # Reversing drug resistance - Curcumin chemosensitization against 5-FU resistance
    {"PMID": "21088503", "TypeID": 1},  # Enhancing drug efficacy - Celastrol + ErbB2 drugs synergy (CI < 1)
    {"PMID": "32872376", "TypeID": 2},  # Decreasing adverse drug reactions - Glycine prevents FOLFOX-induced heart injury
    {"PMID": "29626307", "TypeID": 1}   # Enhancing drug efficacy - FAS combination therapy improves survival
]

# Save to JSON file
with open(output_path, 'w', encoding='utf-8') as f:
    json.dump(results, f, indent=2)

print("Step 5: Results saved to", output_path)
print("\nFinal classification results:")
print(json.dumps(results, indent=2))

# Verify file was created
if os.path.exists(output_path):
    print(f"\n[✓] File successfully created at: {output_path}")
    with open(output_path, 'r') as f:
        content = json.load(f)
        print(f"[✓] Valid JSON with {len(content)} entries")
else:
    print("[✗] File not found!")
</execute>
<observation>Step 5: Results saved to /root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json

Final classification results:
[
  {
    "PMID": "27980427",
    "TypeID": 3
  },
  {
    "PMID": "25653233",
    "TypeID": 3
  },
  {
    "PMID": "23429291",
    "TypeID": 3
  },
  {
    "PMID": "21088503",
    "TypeID": 1
  },
  {
    "PMID": "32872376",
    "TypeID": 2
  },
  {
    "PMID": "29626307",
    "TypeID": 1
  }
]

[✓] File successfully created at: /root/autodl-tmp/biomni_v20260208_pred_results/kimi-k2.5/npcdr_extract_1.json
[✓] Valid JSON with 6 entries
</observation>
Each response must include thinking process followed by either <execute> or <solution> tag. But there are no tags in the current response. Please follow the instruction, fix and regenerate the response again.
Let me provide the final solution with proper formatting.

## Thinking Process:

I have successfully analyzed all 6 PDF papers and classified them into the appropriate therapeutic effect categories. Here's the summary of my analysis:

1. **Paper 27980427**: "Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway" - Focuses on reversing 5-FU resistance in resistant gastric cancer cells. **Type 3**

2. **Paper 25653233**: "Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer" - Focuses on overcoming chemoresistance in 5FU-resistant cells. **Type 3**

3. **Paper 23429291**: "Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil" - Focuses on reducing drug resistance through chemosensitization. **Type 3**

4. **Paper 21088503**: "Anticancer activity of celastrol in combination with ErbB2-targeted therapeutics" - Demonstrates synergistic cytotoxicity with combination index (CI) < 1. **Type 1**

5. **Paper 32872376**: "Dietary Glycine Prevents FOLFOX Chemotherapy-Induced Heart Injury" - Focuses on preventing cardiotoxicity side effects. **Type 2**

6. **Paper 29626307**: "Preoperative fluorouracil, doxorubicin and streptozocin for the treatment of pancreatic neuroendocrine liver metastases" - FAS combination therapy showing improved survival outcomes. **Type 1**

<solution>
[
  {
    "PMID": "27980427",
    "TypeID": 3
  },
  {
    "PMID": "25653233",
    "TypeID": 3
  },
  {
    "PMID": "23429291",
    "TypeID": 3
  },
  {
    "PMID": "21088503",
    "TypeID": 1
  },
  {
    "PMID": "32872376",
    "TypeID": 2
  },
  {
    "PMID": "29626307",
    "TypeID": 1
  }
]
</solution>